Corvus Pharmaceuticals Inc. (CRVS)

Corvus Pharmaceuticals Inc. (CRVS $15.34)
- $15.34 Cap: $1.28B
- View CRVS Profile
- View Questions on CRVS

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

uniQure N.V. (QURE $16.16)
- $16.16 Cap: $1.12B
- View QURE Profile
- View Questions on QURE
Doximity Inc. Class A (DOCS $24.76)
- $24.76 P/E (TTM): 20.31X Cap: $4.50B
- View DOCS Profile
- View Questions on DOCS
ADMA Biologics Inc (ADMA $15.42)
- $15.42 P/E (TTM): 25.25X Cap: $3.77B
- View ADMA Profile
- View Questions on ADMA
National HealthCare Corporation (NHC $166.45)
- $166.45 P/E (TTM): 21.05X Cap: $2.50B
- View NHC Profile
- View Questions on NHC
Corvus Pharmaceuticals Inc. (CRVS $15.34)
- $15.34 Cap: $1.28B
- View CRVS Profile
- View Questions on CRVS

Q: Hi team,

In attempting to increase the health sector and possibly the international percentage of my portfolio, I am considering the following stocks: ADMA,NHC, QURE,DOCS, CRVS.

Would you recommend any of these or any others for a growth portfolio at this time ?

Gratefully,

Jacques IDS

Read Answer Asked by Jacques on March 16, 2026